References
"Medication information." Scleroderma Foundation. Last updated November 16, 2007. http://www.scleroderma.org. Accessed November 2007.
"Occupational Exposure to Solvents and Gender-Related Risk of Systemic Sclerosis: a Metaanalysis of Case-Control Studies." The Journal of Rheumatology. January 2007. http://www.jrheum.com. Accessed November 2007.
"Medications for Scleroderma, Arthritis, Autoimmune and Rheumatic Diseases." The International Scleroderma Network. 2007. http://www.sclero.org. Accessed November 2007.
"Systemic sclerosis (scleroderma) and pregnancy." Uptodate. August 2007. http://patients.uptodate.com. Accessed November 2007.
"Types of scleroderma." MedifocusHealth. June 2007. http://www.medifocushealth.com. Accessed November 2007.
"What you need to know about scleroderma." The Cleveland Clinic. October 2006. http://www.clevelandclinic.org. Accessed November 2007.
"Overview of treatment and prognosis of scleroderma in adults." Uptodate.com. Updated September 2007. http://www.utdol.com. Accessed November 2007.
"Natural remedies for scleroderma." High Beam Encyclopedia. September 2006. http://www.encyclopedia.com. Accessed November 2007.
"Scleroderma Center." Johns Hopkins Medicine. 2007. http://scleroderma.jhmi.edu. Accessed November 2007.
"Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based review." Curr Opin Rheumatol. 2007 Nov;19(6):611-618. http://www.ncbi.nlm.nih.gov. November 2007.
"Autoimmunity and pregnancy." The International Scleroderma Network. 2007. http://www.sclero.org. Accessed November 2007.
"FDA Issues Public Health Advisory on Vioxx as its Manufacturer Voluntarily Withdraws Its Product." U.S. Food and Drug Administration. http://www.fda.gov. Accessed October 1, 2004.
Scleroderma Research Foundation. http://www.srfcure.org. Accessed September 2003.
Clements, PJ, Furst, DE. Williams & Wilkins. 1996.
"Scleroderma." Arthritis Foundation. http://www.arthritis.org. Accessed August 2002.
Medsger, Thomas, Jr. "Chapter 74 - Systemic Sclerosis (Scleroderma): Clinical Aspects." Arthritis and Allied Conditions. Baltimore. 13th ed. Ed. William Koopman. Williams & Wilkins. 1433-1462.
"Questions and Answers About Raynaud's Phenomenon." The National Institute of Arthritis and Musculoskeletal and Skin Diseases. May 2001. http://www.niams.nih.gov. Accessed August 2002.
"Raynaud's Phenomenon." Arthritis Foundation. http://www.arthritis.org. Accessed August 2002.
"Scleroderma" Arthritis Foundation. Brochure No: 835-5325. http://www.arthritis.org. Accessed August 2002.
"Handout on Health: Scleroderma" National Institute of Arthritis and Musculoskeletal Diseases. Published July 2001. http://www.niams.nih.gov. Accessed August 2002.
New Drops Offer Hope for Dry Eyes. Treatment Breaks the Cycle of Inflammation in Dry-Eye Disease. WebMD, April 12, 2000.
Scleroderma Fact Sheet. Scleroderma Foundation. http://www.scleroderma.org. Copyright 2002. Accessed September 2003.
"Scleroderma" EMedicine Journal. January 9, 2002, Vol. 3, No. 1. http://www.emedicine.com. Accessed August 2002.
Garabrant DH, et al. "Scleroderma and Solvent Exposure Among Women" Am J Epidemiol. 2003 March 15;157(6):493-500.
| |
|
View References for this Health Topic
|
Create Date: 3/15/02
Date Last Updated: 12/19/07
Review Date: 12/15/07
|
|